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Abstract
A number of high intensity psychosocial interventions have been shown to be as
efficacious as and more enduring than medications in the treatment of nonpsychotic
depression. Moreover there have been important advances in the development of
strategies to facilitate the selection of the best treatment for a given patient. However, the
demand for services is too great to be met by conventional high intensity approaches
alone. Some of the most exciting work in recent years has focused on the development of
low intensity approaches that can provide benefit to large numbers of people in a cost-
effective fashion.
Introduction
The last several years have seen important innovations in the treatment of depression. We
have learned more about established interventions (particularly with respect to how to
select the best treatment for a given patient aka personalized or individualized
approaches) and novel interventions (or new uses for established interventions) have been
developed and evaluated. Perhaps the most exciting developments have come in the area
of low intensity strategies that aim to deliver therapies with far shorter support time from
the practitioner such as computerized therapy and bibliotherapy (printed manuals). The
evidence base for such approaches continues to develop, and there are suggestions of
equal outcomes to traditional so-called high intensity psychotherapy approaches
delivered as one hour sessions by an expert practitioner, often over 12-20 sessions. We
review these developments in turn.
We consider three types of relative outcomes.1 Efficacy refers to whether an intervention
has a causal effect and can be inferred via clinical trials whenever a treatment is
compared to a control group and found to be better than its absence. Specificity refers to
whether an intervention is more efficacious than the generic effects of simply going into
treatment such as the general effects of feeling listened to, receiving support,
mobilization of hope and the establishment of a working alliance. Superiority refers to
whether an intervention is actually better than alternative “active” interventions such as
another talking therapy or medication. As we shall see, most of the existing psychosocial
interventions are efficacious (they are better than their absence) and some may be
specific (they have active mechanisms that rise above the nonspecific benefits of simply
going into treatment). Whether any one is superior to one another is an ongoing matter of
contention2 and allegiance effects loom large in individual comparisons.3 We also note
that there is an asymmetry in the field; medications cannot be approved for sale unless
they have demonstrated specificity (they must exceed placebo controls in order to be
marketed) whereas it is perfectly reasonable for therapists to charge for psychosocial
interventions that may provide little more than nonspecific support and the promise of
confidentiality from a sympathetic listener.4 In fact, the major portion of the acute effects
produced by interventions for depression are a consequence of these nonspecific
processes,5 although as we shall see some of the cognitive and behavioral interventions
have enduring effects not found for medications that last beyond the end of treatment.6
Established High Intensity Interventions:
Cognitive behavioral therapy (CBT) remains one of the best established of the existing
treatments for unipolar depression. Although labeled as a unitary approach, multiple
different minor modifications of the general model have been developed and evaluated.
CBT has been shown to be as efficacious as antidepressant medications with each
superior to pill-placebo in the treatment of patients with more severe depressions.7 This
finding was confirmed in a recent individual patient level meta-analysis involving over
1700 patients treated in randomized controlled trials (RCTs) comparing the two
monotherapies.8 CBT has been criticized by some as lacking long-term follow-up,
however CBT has an enduring effect after treatment termination not found for
antidepressant medications9. There are indications that this enduring effect might even be
superior prior to continuing remitted patients on antidepressant medicationss.10 Adding
CBT appears to produce a modest 10% increment in rates of recovery over medication
alone, but this increment is heavily moderated; non-chronic patients with more severe
depressions showed a rather large 30% increment, whereas non-chronic patients with less
severe depressions did not need this addition and chronic patients regardless of severity
did not benefit from it (incremental benefits were negligible for each of these latter two
groups).11 DeRubeis and colleagues have developed a novel strategy for generating
algorithms that can identify the best treatment for a given patient. Application of this
personalized advantage index (PAI) to a recent RCT indicated that about a quarter of the
patients randomized to each monotherapy (CBT or antidepressant medications) would
have done better if they had received the other and that overall outcomes would have
been improved by as much as the advantage of antidepressant medications over pill-
placebo if each patient had received optimal treatment.12 The PAI can be applied to any
treatment and could be used to improve the efficiency of health care delivery and to
increase the power and specificity of tests of mechanism. However, this specialist high
intensity CBT approach is maximized when manualized and delivered by trained and
competent practitioners who receive ongoing supervision13. When delivered in robust
ways high efficacy in terms of recovery are achieved14 however results can be more
disappointing where services are introduced without a focus on a consistently delivered
service. There is increasing interest as to whether and how CBT can be delivered via low
intensity interventions such as books (bibliotherapy) and online (see later).
Behavioral Activation represents a partial return to the principles of behavioral medicine
as developed within the 1960’s and 70’s15 and extends the model to include added
concepts such as choosing to do activities that the person values, as well as activities that
provide a sense of pleasure, achievement and closeness to others. It also emphasizes the
importance of engaging in routine/mundane activities such as washing clothes, household
chores and self-care as important ways of preventing further problems from developing.
The focus is still on behavior more than on cognition and instead emphasizes engagement
with potential reinforcers in the environment. Avoidance is a key target for change and
the model argues that when someone is distressed it is a relief not to have to do usual
activities. However, the less people do, the worse they feel and the worse they feel the
less they do, contributing to a vicious cycle of avoidance, which is the target for change.
In a study conducted at its home institution, Behavioral Activation was as efficacious as
antidepressant medications and superior to both CBT and pill-placebo among patients
with more severe depressions16 and as enduring as CBT (with each superior to prior
antidepressant medications) following treatment termination.17 A subsequent study
conducted in Iran found Behavioral Activation superior to antidepressant medications
(albeit at about half the maximum dosage)18 and another in the United Kingdom found it
superior to treatment as usual.19 Trials are currently underway comparing Behavioral
Activation to CBT in primary care settings in the UK20 and rural India21 and an as yet
unpublished trial indicates that it reduces depressive symptoms with no risk of side
effects in antenatal depressed women (S Dimidjian, November 29, 2015, personal
communication). Behavioral Activation appears to be less complicated to learn than CBT
and if its apparent enduring effect proves to be robust it may supplant that more
established intervention. It is possible to train non-specialist nurses to deliver Behavioral
Activation19, and as with CBT, it can be successfully delivered in both high intensity and
low intensity ways22,23Again, there is increasingly a focus on delivering Behavioral
Activation approaches in low intensity ways via the use of worksheets, books and online
therapies with high success.
Mindfulness-based Cognitive Therapy (MBCT) involves an integration of meditation
training with cognitive therapy that is often provided in a group format. MBCT is well
established as a preventive intervention and is often provided to patients who have first
been brought to remission with antidepressant medications or other interventions.24
MBCT is currently recommended to prevent relapse in people who have had 2+ episodes
of depression, however there is a lack of evidence as to whether mindfulness approaches
can aid milder depression or anxiety. Its mindfulness component may carry less stigma
than conventional psychosocial interventions and it may prove to be of particular use in
reducing risk for pre- and postpartum depression in pregnant women who prefer not to
take medications.25 Despite earlier misgivings, recent trials suggest that it also might be
efficacious in the treatment of acute depression26 and that it can be used to prevent the
onset of depression in at least some at-risk adolescents.27 However, again there have been
difficulties delivering the approach effectively in everyday settings when delivered
without clarity of training, delivery and supervision, and again short follow-up times for
many studies has been an issue28, 29.
Acceptance and Commitment Therapy is one of the newer “third wave” behavior
therapies (along with Behavioral Activation and MBCT) that emphasize context and
experiential aspects of psychological experience. It was developed to focus more on
complicated long-standing treatment resistant disorders and has not been as often applied
to patients with diagnosed depressions although change in the symptom of depression
often has been assessed across time. A recent meta-analysis found nearly 40 trials that
assessed depression across the course of treatment in samples with a variety of different
disorders; in those trials, Acceptance and Commitment Therapy produced large within-
group reductions in symptoms and moderate reductions relative to minimal treatment
controls (but not active controls).30 For example, only one study (conducted in Iran)
focused on the treatment of patients who met criteria for major depressive disorders and
cell sizes in that trial were quite small.31 Although not as often studied as the other
interventions with respect to diagnosed depression, it would appear that existing findings
are promising with respect to efficacy if not specificity.
Interpersonal Psychotherapy (IPT) has, until recent years, had one of the most
consistent records of efficacy in controlled trials, demonstrating both efficacy and
specificity across a number of trials.32 That may be in part due to the fact that it has not
been all that widely adopted and as a consequence most of the controlled trials were done
by advocates expert in its implementation. That has changed somewhat in recent years. A
trial coming out of New Zealand found that IPT was less efficacious that CBT in the
treatment of patients with more severe depressions33 or personality disorders34 and
another trial done in Canada found IPT less efficacious than antidepressant medications.35
On the other hand, an even more recent trial from the Netherlands found no differences
between IPT and CBT36 with indications of differential response (moderation) on the part
of different patients.37 At this time it seems fair to say that IPT remains one of the best
established treatments for depression although it is still not widely practiced outside of
certain areas.
Dynamic Psychotherapy remains one of the most widely practiced but least evaluated
psychosocial interventions. In the last decade there has been an increased emphasis on
brief interventions, often characterized by manualized approaches and focused goals.
There have been two recent trials worth noting. In the first, Supportive-Expressive
Therapy, a form of brief dynamic psychotherapy, did not differ from antidepressant
medications (sertraline with non-responders switched to venlafaxine at mid-treatment) or
pill-placebo across sixteen weeks of treatment.38 Within the larger sample, black men did
better in Supportive-Expressive Therapy than they did in either of the two pill conditions
and white women did better in either active intervention than they did in pill-placebo. In a
separate trial conducted in the Netherlands, short-term dynamic psychotherapy did not
differ from CBT with noninferiority shown for the continuous measures of depression but
not for the somewhat disappointingly low categorical remission rates (22.7% overall).39 It
is not clear what conclusions can be drawn from these studies. On the one hand, dynamic
psychotherapy was not inferior to two of the best-established interventions in the field
(antidepressant medications and CBT), but on the other hand, neither study demonstrated
either efficacy or specificity with what were essentially null findings. If dynamic
psychotherapy were a novel medication the FDA would not have counted either as a
positive indication sufficient for marketing. The first trial did include a nonspecific
control condition, but antidepressant medications only exceeded pill-placebo in about
half the trials submitted to the FDA to win marketing approval for more recent
serotonergic medications40 and CBT in the second trial was conducted by a group with no
prior track record with that approach. Neither consideration inspires confidence in the
generalizability of the comparisons.
As an overview, typically evidence-based interventions share three characteristics; they
have a clear structure, focus on problems relevant to the person and build on a
relationship with a practitioner. This relationship has traditionally been extensive in terms
of time and frequency of sessions (up to one hour sessions for 12-20+ weeks). So, a
typical mindfulness course recommends 26 hours of therapy29, and over 20 hours for
treatment resistant depression41. However, can a proportion of people recover equally
well with shorter and more focused interventions?
Established Low intensity interventions
In clinical services there is often a challenge as to how to offer an effective intervention
that is evidence based, well delivered and also cost-effective. In paid-for settings where
there is often a limit to the number of sessions it becomes especially important to test
interventions that potentially can be delivered in shorter, more focused ways, and with
less practitioner time overall; hence low intensity in contrast to the high intensity (longer)
traditional ways of delivering therapies. Bennett-Levy et al42 provides an overview of the
low intensity approaches.
Three key components are emphasized in low intensity delivery:
1) Therapeutic model: Low intensity approaches have been developed and tested across
an increasing range of disorders including depression, anxiety, panic, pain and fatigue
and more. The majority of evaluated interventions to date have used the CBT approach,
reflecting its structured approach and psychoeducational skills-based content that makes
it especially appropriate for low intensity delivery. Increasingly MBCT, Acceptance and
Commitment Therapy and Behavioral Activation approaches also are becoming available
via low intensity interventions as well. Other approaches like brief psychodynamic
therapy also can be delivered in this way43. CBT-based resources (both book and online)
are more effective at treating depression than approaches using psychoeducation alone44.
2) Modality of delivery: Low intensity delivery has at its heart the concept that resource
materials deliver key components of the therapy. This might include delivery via the
media of books (bibliotherapy), and computers (for example computerized CBT- cCBT).
Both approaches lead to equivalent outcomes44. Online approaches can provide
scalability to encompass large number of people; also members of the public are more
likely to endorse online approaches than book-based approaches, and both are seen more
positively when offered with therapist support (i.e. as guided self-help) rather than
unsupported (unguided)45. Some wider issues are also important when making
judgements about what resources to choose to use. Both books and online resources vary
significantly in terms of accessibility and readability and the typical reading age required
for bibliotherapy approaches excludes significant numbers of potential readers46. It has
been suggested that a learning assessment should occur as well as a clinical assessment to
identify choice of low intensity resources47.
3). Amount and type of support: For depression, the efficacy of CBT-based (self-help)
resources improves significantly when accompanied by support from a practitioner. It
appears this support can be delivered effectively by either experts or non-experts in CBT,
and the focus of the support does not need to include additional therapy components44.
Support contacts play a key role in helping encourage and motivate the patient to use the
resources, and help overcome blocks and low motivation in applying what is learned. It
appears there is no difference in outcome when support is delivered face-to-face or by
telephone. Online support (email or chat) is likely to be as efficacious. It is uncertain
whether text-based chat is as effective, although it may have a role in reminding users to
read or test out resources.
Does it work?
An overview of studies suggests that computer-delivered and book-delivered CT appear
equally effective and modality selection should be informed by patient choice44. A review
of studies comparing low and high intensity interventions found equivalent outcomes in
both the short and longer term48. There are many uncertainties however and a recent
large, well-conducted study with an active control found no advantage of cCBT (free or
licensed) over GP usual care49. However that study provided little in the way of active
support for the packages perhaps explaining the result.
Controversies and challenges in low intensity delivery:
1) Who provides the support? A key issue in low intensity working is whether fidelity
to the underlying evidence-based model can be attained. Critics question whether such
approaches provide only a cheap and poorer delivery. This is not borne out by the data, or
national treatment guidelines. Secondly, it is not fully clear whether some subgroups of
people do better with more flexible support from a skilled and trained practitioner, rather
than a generic support worker. In practice, at least in the UK, a majority of accredited
CBT (high intensity) specialists also supplement their work with self-help resources50.
Trials are needed to clarify if this added expertise and knowledge of the CBT model leads
to improved outcomes. Provisional data44 suggests not, however this review examined the
combined results of studies rather than identifying whether specific groups of patients
require added input (for example more complex or chronic presentations).
2) Which patients do well or badly with low intensity approaches? Many clinicians
view CBT-based resources such as cCBT as being less effective than seeing a specialist
practitioner51. They identify patients who might do well as being milder in presentation.
This view is not supported by findings of larger benefits in clinical samples compared to
those who are less unwell44 Also, severity did not predict who failed to engage with or
benefit from low intensity interventions45. It is also unclear whether age affects outcomes.
Conclusions:
It is an interesting time for evidence-based psychological therapies. The evidence base
for traditionally delivered high intensity interventions is now established, reflecting
benefits comparable to antidepressant medication across acute treatment with a long-term
enduring effect (at least for CBT and possibly Behavioral Activation) not found for
medications. Attention has turned to whether similar benefits can be gained by delivering
the same interventions in shorter and more focused ways. There is a growing evidence
base suggesting that at least for CBT and Behavioral Activation, low intensity
interventions can be delivered effectively. However, for both high and low intensity
intervention, the challenge now is the transition from the good results found in well
controlled, manualized and supervised clinical trials, into everyday clinical services.
Much more needs to be known about patient preference, how to engage people in ways
they want to work, and how to offer an approach that is consistently delivered in high
quality ways in order to maximize outcomes.
Four CME questions
1) Perhaps the major advantage that the cognitive and behavioral interventions have over
antidepressant medications is that:
a) they work faster than medications
b) they are more robust in practice
c) they are less expensive to provide
d) they last longer than medications
2) One advantage that Behavioral Activation has over CBT is that:
a) it is less complicated and easier to learn
b) it has an enduring effect not found for CBT
c) it produces fewer behavioral side effects
d) it is less likely to generate stigma than CBT
3). Low intensity interventions for depression:
a) Work best with people experiencing milder symptoms of depression
b) Are best delivered with practitioner support
c). Always use the CBT approach
d). Show maximum benefit when delivered online
4). Low intensity interventions are effective when:
a). Support is delivered face to face compared to by telephone
b). Longer and more sessions of support are offered
c). They are supported by non-mental health specialists
d). They contain a psychoeducational content
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